| Coagulation factor IX |
EU/1/16/1098/003 |
Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
1877.6 |
375.52 |
2253.12 |
4% |
10 |
1887.6 |
377.52 |
2265.12 |
16% |
25 |
1912.6 |
382.52 |
2295.12 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17525/13.12.2018 |
02.04.2019 |
02.04.2019 |
Активен |
15906 |
| Coagulation factor IX |
EU/1/16/1098/003 |
Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
2699.03 |
539.81 |
3238.84 |
4% |
10 |
2709.03 |
541.81 |
3250.84 |
16% |
25 |
2734.03 |
546.81 |
3280.84 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15906 |
| Coagulation factor IX |
EU/1/16/1098/004 |
Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
3755.19 |
751.04 |
4506.23 |
4% |
10 |
3765.19 |
753.04 |
4518.23 |
16% |
25 |
3790.19 |
758.04 |
4548.23 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17526/13.12.2018 |
02.04.2019 |
02.04.2019 |
Активен |
15907 |
| Coagulation factor IX |
EU/1/16/1098/004 |
Alprolix, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
5398.05 |
1079.61 |
6477.66 |
4% |
10 |
5408.05 |
1081.61 |
6489.66 |
16% |
25 |
5433.05 |
1086.61 |
6519.66 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15907 |
| Coagulation factor IX |
EU/1/16/1098/001 |
Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
469.4 |
93.88 |
563.28 |
4% |
10 |
479.4 |
95.88 |
575.28 |
16% |
25 |
504.4 |
100.88 |
605.28 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17527/13.12.2018 |
02.04.2019 |
02.04.2019 |
Активен |
15904 |
| Coagulation factor IX |
EU/1/16/1098/001 |
Alprolix, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
674.76 |
134.95 |
809.71 |
4% |
10 |
684.76 |
136.95 |
821.71 |
16% |
25 |
709.76 |
141.95 |
851.71 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15904 |
| Coagulation factor IX |
EU/1/16/1098/005 |
Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
5632.79 |
1126.56 |
6759.35 |
4% |
10 |
5642.79 |
1128.56 |
6771.35 |
16% |
25 |
5667.79 |
1133.56 |
6801.35 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17528/13.12.2018 |
02.04.2019 |
02.04.2019 |
Активен |
15908 |
| Coagulation factor IX |
EU/1/16/1098/005 |
Alprolix, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
8097.08 |
1619.42 |
9716.5 |
4% |
10 |
8107.08 |
1621.42 |
9728.5 |
16% |
25 |
8132.08 |
1626.42 |
9758.5 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15908 |
| Coagulation factor IX |
EU/1/16/1 098/002 |
Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
938.8 |
187.76 |
1126.56 |
4% |
10 |
948.8 |
189.76 |
1138.56 |
16% |
25 |
973.8 |
194.76 |
1168.56 |
|
НСР-14169/13.10.2017; КП-31/06.03.2019 и НСР-17515/13.12.2018 |
02.04.2019 |
02.04.2019 |
Активен |
15905 |
| Coagulation factor IX |
EU/1/16/1 098/002 |
Alprolix, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
1349.52 |
269.9 |
1619.42 |
4% |
10 |
1359.52 |
271.9 |
1631.42 |
16% |
25 |
1384.52 |
276.9 |
1661.42 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15905 |
| Coagulation factor IX |
EU/1/16/1098/003 |
Alprolix, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial + 1 pre-filled syringe + 1 plunger rod + 1 vial adapter + 1 infusion set + 2 swabs + 2 plasters + 1 gauze |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Strandbergsgatan 49, 11276 Stockholm, Швеция |
2699.03 |
539.81 |
3238.84 |
4% |
10 |
2709.03 |
541.81 |
3250.84 |
16% |
25 |
2734.03 |
546.81 |
3280.84 |
|
НСР-14169/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
15906 |
| Alprostadil |
20020373 |
ALPROSTAPINT, Concentrate for solution for infusion, 500 mcg/1 ml, mg, Pack: 5 |
PINT Pharma GmbH,, Австрия |
PINT Pharma GmbH, Austria |
645.42 |
129.08 |
774.5 |
4% |
10 |
655.42 |
131.08 |
786.5 |
16% |
25 |
680.42 |
136.08 |
816.5 |
Промяна на обстоятелства НСР-14572/08.12.2017 |
КЦ-1610/07.06.2010 |
22.06.2010 |
02.01.2018 |
Активен |
932 |
| Alprostadil |
ІІ-2232/10,06,2008 |
ALPROSTAPINT, Concentrate for solution for infusion, 500 mcg/1 ml, mg, Pack: 5 |
PINT Pharma GmbH,, Австрия |
PINT Pharma GmbH, Austria |
645.42 |
129.08 |
774.5 |
4% |
10 |
655.42 |
131.08 |
786.5 |
16% |
25 |
680.42 |
136.08 |
816.5 |
|
КЦ-1610/07.06.2010 |
22.06.2010 |
22.06.2010 |
Неактивен |
932 |
| Alprostadil |
№ II-12708/29.03.2006 |
ALPROSTAPINT, Concentrate for solution for infusion, 20 mcg/1 ml, mg, Pack: 5 |
Нобел Фарма ЕООД, България |
BAG (Biologishe Analysensystem) GmbH, Germany; Gebro Pharma GmbH, Austria |
111.27 |
22.25 |
133.52 |
4% |
4.45 |
115.72 |
23.14 |
138.86 |
16% |
17.8 |
133.52 |
26.7 |
160.22 |
Цената се заличава с решение НСР-4627/15.09.2014 ( в сила от 16.10.2014) |
НСР-1291/03.10.2013 |
20.11.2013 |
20.11.2013 |
Заличен |
2217 |
| Alprostadil |
№ II-12708/29.03.2006 |
ALPROSTAPINT, Concentrate for solution for infusion, 20 mcg/1 ml, mg, Pack: 5 |
Нобел Фарма ЕООД, България |
BAG (Biologishe Analysensystem) GmbH, Germany; Gebro Pharma GmbH, Austria |
112.46 |
22.49 |
134.95 |
4% |
4.5 |
116.96 |
23.39 |
140.35 |
16% |
17.99 |
134.95 |
26.99 |
161.94 |
промяна на обстоятелства решение КЦ-2341/15.06.2011; КЦ-2342/15.06.2011; КЦ-2309/10.06.2011 |
КЦ-1610/07.06.2010 |
22.06.2010 |
22.06.2010 |
Неактивен |
2217 |
| Allergens products |
II-14862/15.11.2006 |
Alustal, Suspension for injection, 5 ml - Начално лечение: 4 флакона с нарастващи концентрации: 0,01-0,1-1-10 IC/ml или IR/ml; allergen products, ml, Pack: 1 |
Stallergenes S.A., Франция |
Stallergenes S.A., France |
88.01 |
17.6 |
105.61 |
4% |
3.52 |
91.53 |
18.31 |
109.84 |
16% |
14.08 |
105.61 |
21.12 |
126.73 |
Цената е прехвърлена в регистъра на пределните цени с решение НСР-7553/19.11.2015 (в сила от 02.01.2016) |
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Заличен |
587 |
| Allergens products |
II-14862/15.11.2006 |
Alustal, Suspension for injection, 5 ml - Поддържащо лечение: 1 флакон 10 IC/ml или IR/ml;Allergens products, ml, Pack: 1 |
Stallergenes S.A., Франция |
Stallergenes S.A., France |
88.01 |
17.6 |
105.61 |
4% |
3.52 |
91.53 |
18.31 |
109.84 |
16% |
14.08 |
105.61 |
21.12 |
126.73 |
Цената е прехвърлена в регистъра на пределните цени с решение НСР-7553/19.11.2015 (в сила от 02.01.2016) |
КЦ-648/05.03.2009 |
19.03.2009 |
19.03.2009 |
Заличен |
588 |
| Valganciclovir |
20150044 |
Alvanocyt, Film coated tablet, 450, mg, Pack: x 60 (блистери) |
Alvogen IPCo S.àr.l, Люксембург |
Pharmadox Healthcare Ltd., Малта; SC Labormed-Pharma S.A., Румъния |
894.89 |
178.98 |
1073.87 |
4% |
10 |
904.89 |
180.98 |
1085.87 |
16% |
25 |
929.89 |
185.98 |
1115.87 |
|
НСР-5932/01.04.2015.; НСР-9555/17.06.2016; НСР-14177/13.10.2017; НСР-17709/10.01.2019 |
25.01.2019 |
02.02.2019 |
Активен |
3799 |
| Valganciclovir |
20150044 |
Alvanocyt, Film coated tablet, 450, mg, Pack: x 60 (блистери) |
Alvogen IPCo S.àr.l, Люксембург |
Pharmadox Healthcare Ltd., Малта; SC Labormed-Pharma S.A., Румъния |
1013.9 |
202.78 |
1216.68 |
4% |
10 |
1023.9 |
204.78 |
1228.68 |
16% |
25 |
1048.9 |
209.78 |
1258.68 |
|
НСР-5932/01.04.2015.; НСР-9555/17.06.2016; НСР-14177/13.10.2017 |
28.10.2017 |
02.11.2017 |
Неактивен |
3799 |
| Valganciclovir |
20150044 |
Alvanocyt, Film coated tablet, 450, mg, Pack: x 60 (блистери) |
Alvogen IPCo S.àr.l, Люксембург |
Pharmadox Healthcare Ltd., Малта; SC Labormed-Pharma S.A., Румъния |
1295.8 |
259.16 |
1554.96 |
4% |
10 |
1305.8 |
261.16 |
1566.96 |
16% |
25 |
1330.8 |
266.16 |
1596.96 |
|
НСР-5932/01.04.2015.; НСР-9555/17.06.2016 |
02.08.2016 |
02.08.2016 |
Неактивен |
3799 |
| Valganciclovir |
20150044 |
Alvanocyt, Film coated tablet, 450, mg, Pack: 60 (блистери) |
Alvogen IPCo S.àr.l, Люксембург |
Pharmadox Healthcare Ltd., Малта; SC Labormed-Pharma S.A., Румъния |
1683.01 |
336.6 |
2019.61 |
4% |
10 |
1693.01 |
338.6 |
2031.61 |
16% |
25 |
1718.01 |
343.6 |
2061.61 |
|
НСР-5932/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3799 |
| Venlafaxine |
II-1930/16.04.2008 |
Alventa, prolonged‐release capsule, hard, 75, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
2.62 |
0.52 |
3.14 |
7% |
0.18 |
2.8 |
0.56 |
3.36 |
20% |
0.52 |
3.32 |
0.66 |
3.98 |
Цената се вписва в регистъра на пределните цени с решение НСР-2658/03.02.2014 |
КЦРР-2846/20.03.2013. |
08.07.2013 |
08.07.2013 |
Заличен |
1906 |
| Venlafaxine |
II-1930/16.04.2008 |
Alventa, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
4.46 |
0.89 |
5.35 |
7% |
0.31 |
4.77 |
0.95 |
5.72 |
20% |
0.89 |
5.66 |
1.13 |
6.79 |
Цената се вписва в регистъра на пределните цени с решение НСР-2657/03.02.2014 |
КЦРР-2847/20.03.2013 |
17.04.2013 |
17.04.2013 |
Заличен |
1806 |
| Venlafaxine |
II-1930/16,04,2008, |
Alventa, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
35.97 |
7.19 |
43.16 |
4% |
1.44 |
37.41 |
7.48 |
44.89 |
16% |
5.76 |
43.17 |
8.63 |
51.8 |
|
КЦ-326/28.11.2008 |
30.12.2008 |
30.12.2008 |
Неактивен |
1806 |
| Venlafaxine |
II-1929/16,04,2008, |
Alventa, prolonged‐release capsule, hard, 75, mg, Pack: 28 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
17.97 |
3.59 |
21.56 |
6% |
1.08 |
19.05 |
3.81 |
22.86 |
18% |
3.23 |
22.28 |
4.46 |
26.74 |
|
КЦ-326/28.11.2008 |
30.12.2008 |
30.12.2008 |
Неактивен |
1906 |